Jazz Pharma Acquires GW Pharma for $7.2 Billion

Cannabis Business Times
Feb 3, 2021, 12:48 pm289 pts
In a blockbuster deal to kick off the 2021 international cannabis M&A season, Jazz Pharmaceuticals has inked a deal to acquire GW Pharmaceuticals, manufacturer of the FDA- and DEA-approved Epidiolex, to the tune of $7.2 billion. As Bloomberg noted, GW’s stock skyrocketed about 46% Wednesday morning as the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas Hemp Business Council Supports Protections for Minors 77

Webinar Replay | Cannabis Without Borders 76

Scutari Endorses 1 Plant Home Grow, State Bank for Cannabis Entrepreneurs if Sherill Elected 75

California cannabis tax cut inches forward as state industry lags behind 60

Scutari Endorses 1 Plant Home Grow, State Bank for Cannabis Entrepreneurs if Sherrill Elected 60

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.